avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSMUSG00000023852.7 | chromodomain helicase DNA binding protein 1 |
Pml
|
ENSMUSG00000036986.10 | promyelocytic leukemia |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pml | mm10_v2_chr9_-_58249660_58249672 | -0.54 | 6.7e-04 | Click! |
Chd1 | mm10_v2_chr17_+_15704963_15704994 | 0.36 | 3.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_44173271 | 11.12 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr16_+_64851991 | 10.94 |
ENSMUST00000067744.7
|
Cggbp1
|
CGG triplet repeat binding protein 1 |
chr16_+_44173239 | 10.31 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr5_-_53213447 | 9.72 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr8_-_84800344 | 9.33 |
ENSMUST00000099070.3
|
Nfix
|
nuclear factor I/X |
chr8_-_84800024 | 9.19 |
ENSMUST00000126806.1
ENSMUST00000076715.6 |
Nfix
|
nuclear factor I/X |
chr2_+_18677002 | 9.15 |
ENSMUST00000028071.6
|
Bmi1
|
Bmi1 polycomb ring finger oncogene |
chr1_+_166254095 | 8.89 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chrX_-_162888426 | 8.75 |
ENSMUST00000033723.3
|
Syap1
|
synapse associated protein 1 |
chr11_-_106920359 | 8.43 |
ENSMUST00000167787.1
ENSMUST00000092517.2 |
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr2_+_58567360 | 8.29 |
ENSMUST00000071543.5
|
Upp2
|
uridine phosphorylase 2 |
chr19_+_36554661 | 8.25 |
ENSMUST00000169036.2
ENSMUST00000047247.5 |
Hectd2
|
HECT domain containing 2 |
chr12_-_4477138 | 8.20 |
ENSMUST00000085814.3
|
Ncoa1
|
nuclear receptor coactivator 1 |
chr18_+_64340225 | 8.01 |
ENSMUST00000175965.2
ENSMUST00000115145.3 |
Onecut2
|
one cut domain, family member 2 |
chr10_+_39732099 | 7.65 |
ENSMUST00000019986.6
|
Rev3l
|
REV3-like, catalytic subunit of DNA polymerase zeta RAD54 like (S. cerevisiae) |
chr4_+_116877376 | 7.63 |
ENSMUST00000044823.3
|
Zswim5
|
zinc finger SWIM-type containing 5 |
chr14_-_45529964 | 7.43 |
ENSMUST00000150660.1
|
Fermt2
|
fermitin family homolog 2 (Drosophila) |
chr11_-_69369377 | 7.39 |
ENSMUST00000092971.6
ENSMUST00000108661.1 |
Chd3
|
chromodomain helicase DNA binding protein 3 |
chr11_-_107132114 | 7.37 |
ENSMUST00000106762.1
ENSMUST00000106763.1 |
Bptf
|
bromodomain PHD finger transcription factor |
chr5_-_96161742 | 6.98 |
ENSMUST00000129646.1
ENSMUST00000113005.2 ENSMUST00000154500.1 ENSMUST00000141383.1 |
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chrX_-_162643575 | 6.94 |
ENSMUST00000101102.1
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chr4_-_105109829 | 6.86 |
ENSMUST00000030243.7
|
Prkaa2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr13_-_29984219 | 6.85 |
ENSMUST00000146092.1
|
E2f3
|
E2F transcription factor 3 |
chr7_-_43489967 | 6.84 |
ENSMUST00000107974.1
|
Iglon5
|
IgLON family member 5 |
chr2_-_37703275 | 6.82 |
ENSMUST00000072186.5
|
Strbp
|
spermatid perinuclear RNA binding protein |
chr12_+_108334341 | 6.76 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr10_+_39732364 | 6.53 |
ENSMUST00000164763.1
|
Rev3l
|
REV3-like, catalytic subunit of DNA polymerase zeta RAD54 like (S. cerevisiae) |
chr15_-_3583191 | 6.46 |
ENSMUST00000069451.4
|
Ghr
|
growth hormone receptor |
chr7_+_44590886 | 6.39 |
ENSMUST00000107906.3
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chr7_+_44384604 | 6.38 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr11_-_120660565 | 6.32 |
ENSMUST00000106177.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr4_+_97777780 | 6.27 |
ENSMUST00000107062.2
ENSMUST00000052018.5 ENSMUST00000107057.1 |
Nfia
|
nuclear factor I/A |
chr17_+_46383725 | 6.26 |
ENSMUST00000113481.1
ENSMUST00000138127.1 |
Zfp318
|
zinc finger protein 318 |
chr13_-_43480973 | 6.23 |
ENSMUST00000144326.2
|
Ranbp9
|
RAN binding protein 9 |
chr17_-_88065028 | 6.17 |
ENSMUST00000130379.1
|
Fbxo11
|
F-box protein 11 |
chr8_+_76899772 | 6.14 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr3_+_66981352 | 6.10 |
ENSMUST00000162036.1
|
Rsrc1
|
arginine/serine-rich coiled-coil 1 |
chr5_+_129941949 | 6.08 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr5_+_43233928 | 6.02 |
ENSMUST00000114066.1
ENSMUST00000114065.1 |
Cpeb2
|
cytoplasmic polyadenylation element binding protein 2 |
chr14_-_31830402 | 5.99 |
ENSMUST00000014640.7
|
Ankrd28
|
ankyrin repeat domain 28 |
chr6_-_119848059 | 5.98 |
ENSMUST00000184864.1
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr16_+_81200697 | 5.97 |
ENSMUST00000067602.3
ENSMUST00000037785.7 |
Ncam2
|
neural cell adhesion molecule 2 |
chr11_-_68386974 | 5.96 |
ENSMUST00000135141.1
|
Ntn1
|
netrin 1 |
chr15_-_3583146 | 5.94 |
ENSMUST00000110698.2
|
Ghr
|
growth hormone receptor |
chr13_-_9764431 | 5.92 |
ENSMUST00000154994.1
ENSMUST00000146039.1 ENSMUST00000110635.1 ENSMUST00000110638.1 |
Zmynd11
|
zinc finger, MYND domain containing 11 |
chr14_-_56811464 | 5.91 |
ENSMUST00000173954.1
|
Zmym5
|
zinc finger, MYM-type 5 |
chr5_-_65697856 | 5.91 |
ENSMUST00000031104.6
|
Pds5a
|
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
chr2_+_4718145 | 5.80 |
ENSMUST00000056914.6
|
Bend7
|
BEN domain containing 7 |
chr13_-_71963713 | 5.74 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr2_-_5714490 | 5.73 |
ENSMUST00000044009.7
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr17_-_79020816 | 5.73 |
ENSMUST00000168887.1
ENSMUST00000119284.1 |
Prkd3
|
protein kinase D3 |
chr5_-_123684275 | 5.72 |
ENSMUST00000111561.1
|
Clip1
|
CAP-GLY domain containing linker protein 1 |
chr14_-_56811716 | 5.72 |
ENSMUST00000039812.9
ENSMUST00000111285.2 |
Zmym5
|
zinc finger, MYM-type 5 |
chr10_-_83337440 | 5.70 |
ENSMUST00000126617.1
|
Slc41a2
|
solute carrier family 41, member 2 |
chr2_+_4717825 | 5.69 |
ENSMUST00000184139.1
ENSMUST00000115022.1 |
Bend7
|
BEN domain containing 7 |
chr6_-_119848093 | 5.65 |
ENSMUST00000079582.4
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr11_+_21091291 | 5.57 |
ENSMUST00000093290.5
|
Peli1
|
pellino 1 |
chr10_-_63339023 | 5.56 |
ENSMUST00000177694.1
ENSMUST00000020257.6 ENSMUST00000105442.2 |
Sirt1
|
sirtuin 1 |
chr17_+_6106880 | 5.53 |
ENSMUST00000149756.1
|
Tulp4
|
tubby like protein 4 |
chr5_+_88886809 | 5.52 |
ENSMUST00000148750.1
|
Slc4a4
|
solute carrier family 4 (anion exchanger), member 4 |
chr9_+_55326913 | 5.52 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chrX_+_99821021 | 5.48 |
ENSMUST00000096363.2
|
Tmem28
|
transmembrane protein 28 |
chr18_-_39490649 | 5.46 |
ENSMUST00000115567.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr10_-_81430966 | 5.44 |
ENSMUST00000117966.1
|
Nfic
|
nuclear factor I/C |
chr2_-_160872829 | 5.44 |
ENSMUST00000176141.1
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr17_+_6106464 | 5.44 |
ENSMUST00000142030.1
|
Tulp4
|
tubby like protein 4 |
chr15_-_10470490 | 5.41 |
ENSMUST00000136591.1
|
Dnajc21
|
DnaJ (Hsp40) homolog, subfamily C, member 21 |
chr17_+_4994904 | 5.39 |
ENSMUST00000092723.4
ENSMUST00000115797.2 |
Arid1b
|
AT rich interactive domain 1B (SWI-like) |
chr17_+_64600702 | 5.39 |
ENSMUST00000086723.3
|
Man2a1
|
mannosidase 2, alpha 1 |
chr7_+_57591147 | 5.38 |
ENSMUST00000039697.7
|
Gabrb3
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
chr12_+_71016658 | 5.35 |
ENSMUST00000125125.1
|
Arid4a
|
AT rich interactive domain 4A (RBP1-like) |
chr11_+_23306884 | 5.34 |
ENSMUST00000180046.1
|
Usp34
|
ubiquitin specific peptidase 34 |
chr1_-_52500679 | 5.29 |
ENSMUST00000069792.7
|
Nab1
|
Ngfi-A binding protein 1 |
chrX_+_161717498 | 5.27 |
ENSMUST00000061514.7
|
Rai2
|
retinoic acid induced 2 |
chrX_+_140664908 | 5.26 |
ENSMUST00000112990.1
ENSMUST00000112988.1 |
Mid2
|
midline 2 |
chrX_+_13071470 | 5.26 |
ENSMUST00000169594.2
|
Usp9x
|
ubiquitin specific peptidase 9, X chromosome |
chr11_+_94211431 | 5.20 |
ENSMUST00000041589.5
|
Tob1
|
transducer of ErbB-2.1 |
chr11_-_26210553 | 5.17 |
ENSMUST00000101447.3
|
5730522E02Rik
|
RIKEN cDNA 5730522E02 gene |
chrX_-_60403947 | 5.17 |
ENSMUST00000033480.6
ENSMUST00000101527.2 |
Atp11c
|
ATPase, class VI, type 11C |
chr10_+_42761483 | 5.13 |
ENSMUST00000019937.4
|
Sec63
|
SEC63-like (S. cerevisiae) |
chrX_-_162643629 | 5.05 |
ENSMUST00000112334.1
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chrX_+_71364901 | 5.03 |
ENSMUST00000132837.1
|
Mtmr1
|
myotubularin related protein 1 |
chr4_+_129820198 | 5.03 |
ENSMUST00000030578.7
|
Ptp4a2
|
protein tyrosine phosphatase 4a2 |
chr11_+_21239279 | 4.98 |
ENSMUST00000006221.7
ENSMUST00000109578.1 |
Vps54
|
vacuolar protein sorting 54 (yeast) |
chr10_-_88503912 | 4.95 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr9_-_59486323 | 4.95 |
ENSMUST00000165322.1
|
Arih1
|
ariadne ubiquitin-conjugating enzyme E2 binding protein homolog 1 (Drosophila) |
chr5_-_45857473 | 4.91 |
ENSMUST00000016026.7
ENSMUST00000067997.6 ENSMUST00000045586.6 |
Lcorl
|
ligand dependent nuclear receptor corepressor-like |
chr19_+_37697792 | 4.91 |
ENSMUST00000025946.5
|
Cyp26a1
|
cytochrome P450, family 26, subfamily a, polypeptide 1 |
chr1_-_10232670 | 4.90 |
ENSMUST00000088615.4
ENSMUST00000131556.1 |
Arfgef1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
chr14_-_45530118 | 4.86 |
ENSMUST00000045905.6
|
Fermt2
|
fermitin family homolog 2 (Drosophila) |
chr4_-_46991842 | 4.86 |
ENSMUST00000107749.2
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr6_-_119848120 | 4.85 |
ENSMUST00000183703.1
ENSMUST00000183911.1 |
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr16_-_46496955 | 4.84 |
ENSMUST00000023335.6
ENSMUST00000023334.8 |
Pvrl3
|
poliovirus receptor-related 3 |
chr13_-_9764865 | 4.82 |
ENSMUST00000128658.1
|
Zmynd11
|
zinc finger, MYND domain containing 11 |
chr14_-_34502522 | 4.80 |
ENSMUST00000171551.1
|
Bmpr1a
|
bone morphogenetic protein receptor, type 1A |
chr1_+_167598450 | 4.80 |
ENSMUST00000111386.1
ENSMUST00000111384.1 |
Rxrg
|
retinoid X receptor gamma |
chr13_-_107890059 | 4.79 |
ENSMUST00000105097.2
|
Zswim6
|
zinc finger SWIM-type containing 6 |
chr15_+_87625214 | 4.79 |
ENSMUST00000068088.6
|
Fam19a5
|
family with sequence similarity 19, member A5 |
chr8_-_104395765 | 4.76 |
ENSMUST00000179802.1
|
Cmtm4
|
CKLF-like MARVEL transmembrane domain containing 4 |
chr16_-_46496772 | 4.74 |
ENSMUST00000149901.1
ENSMUST00000096052.2 |
Pvrl3
|
poliovirus receptor-related 3 |
chr10_+_98915117 | 4.73 |
ENSMUST00000020107.7
|
Atp2b1
|
ATPase, Ca++ transporting, plasma membrane 1 |
chr2_+_69897255 | 4.72 |
ENSMUST00000131553.1
|
Ubr3
|
ubiquitin protein ligase E3 component n-recognin 3 |
chr15_-_91049823 | 4.71 |
ENSMUST00000088614.5
ENSMUST00000100304.4 ENSMUST00000067205.8 ENSMUST00000109288.2 ENSMUST00000109287.2 |
Kif21a
|
kinesin family member 21A |
chr11_-_106613370 | 4.71 |
ENSMUST00000128933.1
|
Tex2
|
testis expressed gene 2 |
chr14_+_14703025 | 4.65 |
ENSMUST00000057015.6
|
Slc4a7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
chr9_+_55149364 | 4.65 |
ENSMUST00000121677.1
|
Ube2q2
|
ubiquitin-conjugating enzyme E2Q (putative) 2 |
chr19_+_23141183 | 4.64 |
ENSMUST00000036884.1
|
Klf9
|
Kruppel-like factor 9 |
chr16_-_96082389 | 4.62 |
ENSMUST00000099502.2
ENSMUST00000023631.8 ENSMUST00000113829.1 ENSMUST00000153398.1 |
Brwd1
|
bromodomain and WD repeat domain containing 1 |
chr7_+_44384098 | 4.62 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
chr12_-_108275409 | 4.59 |
ENSMUST00000136175.1
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr10_-_88503952 | 4.59 |
ENSMUST00000020253.8
|
Chpt1
|
choline phosphotransferase 1 |
chr5_+_73491026 | 4.58 |
ENSMUST00000063882.5
ENSMUST00000113558.1 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr9_+_100643755 | 4.57 |
ENSMUST00000133388.1
|
Stag1
|
stromal antigen 1 |
chr18_+_24205937 | 4.57 |
ENSMUST00000164998.1
|
Galnt1
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
chr1_-_80340311 | 4.55 |
ENSMUST00000164108.1
|
Cul3
|
cullin 3 |
chr17_+_86963279 | 4.55 |
ENSMUST00000139344.1
|
Rhoq
|
ras homolog gene family, member Q |
chr4_+_95967322 | 4.50 |
ENSMUST00000107083.1
|
Hook1
|
hook homolog 1 (Drosophila) |
chr2_+_109917639 | 4.45 |
ENSMUST00000046548.7
ENSMUST00000111037.2 |
Lgr4
|
leucine-rich repeat-containing G protein-coupled receptor 4 |
chr5_+_43233463 | 4.45 |
ENSMUST00000169035.1
ENSMUST00000166713.1 |
Cpeb2
|
cytoplasmic polyadenylation element binding protein 2 |
chr5_+_124445461 | 4.45 |
ENSMUST00000100709.2
|
Setd8
|
SET domain containing (lysine methyltransferase) 8 |
chr7_+_24481991 | 4.42 |
ENSMUST00000068023.7
|
Cadm4
|
cell adhesion molecule 4 |
chr5_-_65435717 | 4.41 |
ENSMUST00000117542.1
|
Ugdh
|
UDP-glucose dehydrogenase |
chr12_-_104865076 | 4.40 |
ENSMUST00000109937.1
ENSMUST00000109936.1 |
Clmn
|
calmin |
chr8_-_64849818 | 4.40 |
ENSMUST00000034017.7
|
Klhl2
|
kelch-like 2, Mayven |
chr1_+_167598384 | 4.39 |
ENSMUST00000015987.3
|
Rxrg
|
retinoid X receptor gamma |
chr9_+_100643605 | 4.36 |
ENSMUST00000041418.6
|
Stag1
|
stromal antigen 1 |
chr17_-_88065291 | 4.34 |
ENSMUST00000005504.8
|
Fbxo11
|
F-box protein 11 |
chr11_+_108920800 | 4.30 |
ENSMUST00000140821.1
|
Axin2
|
axin2 |
chr6_-_23839137 | 4.28 |
ENSMUST00000166458.2
ENSMUST00000142913.2 ENSMUST00000115357.1 ENSMUST00000069074.7 ENSMUST00000115361.2 ENSMUST00000018122.7 ENSMUST00000115355.1 ENSMUST00000115356.2 |
Cadps2
|
Ca2+-dependent activator protein for secretion 2 |
chr18_+_7869707 | 4.28 |
ENSMUST00000166062.1
ENSMUST00000169010.1 |
Wac
|
WW domain containing adaptor with coiled-coil |
chr13_-_9764943 | 4.24 |
ENSMUST00000110634.1
|
Zmynd11
|
zinc finger, MYND domain containing 11 |
chr4_-_114908892 | 4.22 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr7_-_114415128 | 4.22 |
ENSMUST00000163996.1
|
4933406I18Rik
|
RIKEN cDNA 4933406I18 gene |
chr15_+_54571358 | 4.21 |
ENSMUST00000025356.2
|
Mal2
|
mal, T cell differentiation protein 2 |
chr4_+_53440516 | 4.20 |
ENSMUST00000107651.2
ENSMUST00000107647.1 |
Slc44a1
|
solute carrier family 44, member 1 |
chr2_-_80581234 | 4.20 |
ENSMUST00000028386.5
|
Nckap1
|
NCK-associated protein 1 |
chr11_-_107131922 | 4.20 |
ENSMUST00000057892.8
|
Bptf
|
bromodomain PHD finger transcription factor |
chr9_-_86695897 | 4.19 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr6_+_54816906 | 4.19 |
ENSMUST00000079869.6
|
Znrf2
|
zinc and ring finger 2 |
chr10_-_17947997 | 4.18 |
ENSMUST00000037879.6
|
Heca
|
headcase homolog (Drosophila) |
chr6_+_145746739 | 4.17 |
ENSMUST00000111704.1
|
Rassf8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
chr4_-_123664725 | 4.16 |
ENSMUST00000147030.1
|
Macf1
|
microtubule-actin crosslinking factor 1 |
chr10_+_19934472 | 4.16 |
ENSMUST00000095806.3
ENSMUST00000120259.1 |
Map3k5
|
mitogen-activated protein kinase kinase kinase 5 |
chr1_+_39193731 | 4.12 |
ENSMUST00000173050.1
|
Npas2
|
neuronal PAS domain protein 2 |
chr9_+_77754526 | 4.12 |
ENSMUST00000034905.8
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr5_+_65764073 | 4.11 |
ENSMUST00000138239.1
ENSMUST00000087264.3 |
N4bp2
|
NEDD4 binding protein 2 |
chrX_-_70365052 | 4.07 |
ENSMUST00000101509.2
|
Ids
|
iduronate 2-sulfatase |
chr5_-_123684289 | 4.06 |
ENSMUST00000111564.1
ENSMUST00000063905.5 |
Clip1
|
CAP-GLY domain containing linker protein 1 |
chr2_-_160872985 | 4.06 |
ENSMUST00000109460.1
ENSMUST00000127201.1 |
Zhx3
|
zinc fingers and homeoboxes 3 |
chr7_-_16614937 | 4.04 |
ENSMUST00000171937.1
ENSMUST00000075845.4 |
Grlf1
|
glucocorticoid receptor DNA binding factor 1 |
chr12_+_111039334 | 4.00 |
ENSMUST00000084968.7
|
Rcor1
|
REST corepressor 1 |
chr11_+_23306910 | 3.98 |
ENSMUST00000137823.1
|
Usp34
|
ubiquitin specific peptidase 34 |
chr15_+_41788979 | 3.98 |
ENSMUST00000170127.1
|
Oxr1
|
oxidation resistance 1 |
chr6_-_39725193 | 3.97 |
ENSMUST00000101497.3
|
Braf
|
Braf transforming gene |
chr2_-_90580578 | 3.96 |
ENSMUST00000168621.2
|
Ptprj
|
protein tyrosine phosphatase, receptor type, J |
chr14_-_33447142 | 3.95 |
ENSMUST00000111944.3
ENSMUST00000022504.5 ENSMUST00000111945.2 |
Mapk8
|
mitogen-activated protein kinase 8 |
chr3_-_122619442 | 3.95 |
ENSMUST00000162947.1
|
Fnbp1l
|
formin binding protein 1-like |
chr18_+_57878620 | 3.93 |
ENSMUST00000115366.2
|
Slc12a2
|
solute carrier family 12, member 2 |
chr18_-_39489880 | 3.93 |
ENSMUST00000152853.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr12_+_108792946 | 3.92 |
ENSMUST00000021692.7
|
Yy1
|
YY1 transcription factor |
chr3_-_148989316 | 3.92 |
ENSMUST00000098518.2
|
Lphn2
|
latrophilin 2 |
chr11_-_68386821 | 3.91 |
ENSMUST00000021284.3
|
Ntn1
|
netrin 1 |
chr6_-_124917939 | 3.91 |
ENSMUST00000032216.6
|
Ptms
|
parathymosin |
chr1_+_191718389 | 3.87 |
ENSMUST00000110856.1
ENSMUST00000130876.1 |
Lpgat1
|
lysophosphatidylglycerol acyltransferase 1 |
chr2_+_102659213 | 3.86 |
ENSMUST00000111213.1
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr15_-_3582596 | 3.85 |
ENSMUST00000161770.1
|
Ghr
|
growth hormone receptor |
chr17_+_13760502 | 3.85 |
ENSMUST00000139347.1
ENSMUST00000156591.1 ENSMUST00000170827.2 ENSMUST00000139666.1 ENSMUST00000137784.1 ENSMUST00000137708.1 ENSMUST00000150848.1 |
Mllt4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
chr3_+_32397671 | 3.80 |
ENSMUST00000108243.1
|
Pik3ca
|
phosphatidylinositol 3-kinase, catalytic, alpha polypeptide |
chr19_+_53677286 | 3.78 |
ENSMUST00000095969.3
ENSMUST00000164202.1 |
Rbm20
|
RNA binding motif protein 20 |
chr7_-_74554474 | 3.77 |
ENSMUST00000134539.1
ENSMUST00000026897.7 ENSMUST00000098371.2 |
Slco3a1
|
solute carrier organic anion transporter family, member 3a1 |
chr11_-_106612928 | 3.77 |
ENSMUST00000042780.7
|
Tex2
|
testis expressed gene 2 |
chr4_-_129248431 | 3.74 |
ENSMUST00000052602.5
|
C77080
|
expressed sequence C77080 |
chr19_-_29805989 | 3.73 |
ENSMUST00000177155.1
ENSMUST00000059484.7 |
9930021J03Rik
|
RIKEN cDNA 9930021J03 gene |
chr11_+_88068242 | 3.72 |
ENSMUST00000018521.4
|
Vezf1
|
vascular endothelial zinc finger 1 |
chr2_-_80581380 | 3.71 |
ENSMUST00000111760.2
|
Nckap1
|
NCK-associated protein 1 |
chr11_-_97280332 | 3.70 |
ENSMUST00000168743.1
|
Npepps
|
aminopeptidase puromycin sensitive |
chr13_+_46669517 | 3.69 |
ENSMUST00000099547.3
|
C78339
|
expressed sequence C78339 |
chr2_+_74668207 | 3.68 |
ENSMUST00000001872.4
|
Hoxd13
|
homeobox D13 |
chr3_+_40950631 | 3.68 |
ENSMUST00000048490.6
|
Larp1b
|
La ribonucleoprotein domain family, member 1B |
chr10_-_7956223 | 3.68 |
ENSMUST00000146444.1
|
Tab2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
chr15_-_31367527 | 3.67 |
ENSMUST00000076942.4
ENSMUST00000123325.1 ENSMUST00000110410.2 |
Ankrd33b
|
ankyrin repeat domain 33B |
chr7_-_34654342 | 3.67 |
ENSMUST00000108069.1
|
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chr6_-_72235559 | 3.66 |
ENSMUST00000042646.7
|
Atoh8
|
atonal homolog 8 (Drosophila) |
chr8_-_91801948 | 3.65 |
ENSMUST00000175795.1
|
Irx3
|
Iroquois related homeobox 3 (Drosophila) |
chr18_-_16809233 | 3.65 |
ENSMUST00000025166.7
|
Cdh2
|
cadherin 2 |
chrX_+_77511002 | 3.62 |
ENSMUST00000088217.5
|
Tbl1x
|
transducin (beta)-like 1 X-linked |
chrX_+_161717055 | 3.62 |
ENSMUST00000112338.1
|
Rai2
|
retinoic acid induced 2 |
chr3_-_89322883 | 3.61 |
ENSMUST00000029673.5
|
Efna3
|
ephrin A3 |
chr17_-_64331817 | 3.60 |
ENSMUST00000172733.1
ENSMUST00000172818.1 |
Pja2
|
praja 2, RING-H2 motif containing |
chr19_+_32757497 | 3.60 |
ENSMUST00000013807.7
|
Pten
|
phosphatase and tensin homolog |
chr9_+_108692116 | 3.60 |
ENSMUST00000035220.6
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr4_-_70534904 | 3.60 |
ENSMUST00000107359.2
|
Megf9
|
multiple EGF-like-domains 9 |
chr4_+_20008357 | 3.60 |
ENSMUST00000117632.1
ENSMUST00000098244.1 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr5_-_65435881 | 3.59 |
ENSMUST00000031103.7
|
Ugdh
|
UDP-glucose dehydrogenase |
chr4_-_57143437 | 3.59 |
ENSMUST00000095076.3
ENSMUST00000030142.3 |
Epb4.1l4b
|
erythrocyte protein band 4.1-like 4b |
chr4_+_47353283 | 3.58 |
ENSMUST00000044234.7
|
Tgfbr1
|
transforming growth factor, beta receptor I |
chr11_-_97280470 | 3.57 |
ENSMUST00000167806.1
ENSMUST00000172108.1 |
Npepps
|
aminopeptidase puromycin sensitive |
chr11_+_102761402 | 3.57 |
ENSMUST00000103081.4
ENSMUST00000068150.5 |
Adam11
|
a disintegrin and metallopeptidase domain 11 |
chr10_+_80329953 | 3.56 |
ENSMUST00000105358.1
ENSMUST00000105357.1 ENSMUST00000105354.1 ENSMUST00000105355.1 |
Reep6
|
receptor accessory protein 6 |
chr1_+_138963709 | 3.55 |
ENSMUST00000168527.1
|
Dennd1b
|
DENN/MADD domain containing 1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
3.2 | 16.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
3.1 | 9.2 | GO:0048338 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
2.8 | 8.5 | GO:0006507 | GPI anchor release(GO:0006507) |
2.5 | 15.1 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
2.4 | 9.7 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
2.3 | 6.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
2.2 | 4.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.2 | 8.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.1 | 6.4 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
2.1 | 12.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
2.1 | 2.1 | GO:1904412 | regulation of cardiac ventricle development(GO:1904412) |
2.0 | 6.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.9 | 5.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.9 | 11.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.9 | 5.7 | GO:0060365 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
1.9 | 5.6 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
1.9 | 5.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
1.8 | 9.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.8 | 7.3 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
1.8 | 7.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.8 | 18.1 | GO:0046449 | creatinine metabolic process(GO:0046449) |
1.7 | 12.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
1.7 | 1.7 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
1.7 | 5.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.7 | 8.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.7 | 5.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.7 | 6.6 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
1.6 | 11.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.6 | 6.5 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
1.6 | 7.9 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.6 | 4.7 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
1.6 | 6.3 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.6 | 4.7 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
1.6 | 7.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.5 | 6.1 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.5 | 4.6 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
1.5 | 4.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
1.5 | 5.9 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.5 | 8.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.5 | 7.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.4 | 7.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.4 | 11.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.4 | 2.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.4 | 1.4 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
1.4 | 5.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.4 | 6.9 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
1.3 | 5.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.3 | 4.0 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
1.3 | 5.3 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.3 | 5.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.3 | 1.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.3 | 3.8 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
1.3 | 5.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.2 | 2.5 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
1.2 | 4.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.2 | 7.2 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.2 | 4.8 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.2 | 3.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.2 | 5.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.2 | 1.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
1.2 | 1.2 | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
1.2 | 3.5 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.2 | 3.5 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.1 | 3.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
1.1 | 3.4 | GO:0097402 | neuroblast migration(GO:0097402) |
1.1 | 4.6 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
1.1 | 8.0 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 7.9 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.1 | 10.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.1 | 3.3 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
1.1 | 3.3 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
1.1 | 4.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 5.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
1.1 | 4.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.1 | 5.4 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.1 | 19.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.1 | 1.1 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
1.1 | 3.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
1.1 | 4.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.1 | 5.3 | GO:0070178 | D-serine metabolic process(GO:0070178) |
1.0 | 3.1 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
1.0 | 11.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
1.0 | 6.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.0 | 2.0 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.0 | 7.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
1.0 | 2.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
1.0 | 5.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.0 | 16.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.0 | 6.0 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 5.9 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
1.0 | 2.9 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
1.0 | 3.9 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.0 | 3.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.0 | 3.9 | GO:0021502 | neural fold elevation formation(GO:0021502) |
1.0 | 2.9 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.0 | 7.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.0 | 2.9 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 2.9 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.0 | 10.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.0 | 5.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.0 | 4.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.0 | 3.8 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.9 | 0.9 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.9 | 1.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.9 | 3.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.9 | 2.8 | GO:0097274 | urea homeostasis(GO:0097274) |
0.9 | 2.8 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.9 | 5.5 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.9 | 6.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.9 | 9.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.9 | 2.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.9 | 0.9 | GO:1901355 | response to rapamycin(GO:1901355) |
0.9 | 7.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.9 | 2.7 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.9 | 2.7 | GO:0015866 | ADP transport(GO:0015866) |
0.9 | 2.7 | GO:0090427 | activation of meiosis(GO:0090427) |
0.9 | 2.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.9 | 0.9 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.9 | 1.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.9 | 4.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.9 | 3.5 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.9 | 6.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.8 | 4.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 2.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.8 | 0.8 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.8 | 2.5 | GO:0016598 | protein arginylation(GO:0016598) |
0.8 | 4.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.8 | 1.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.8 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 2.5 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.8 | 4.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 7.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.8 | 7.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.8 | 1.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.8 | 5.6 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 1.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.8 | 2.4 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.8 | 2.4 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.8 | 6.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.8 | 3.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.8 | 3.2 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.8 | 8.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.8 | 7.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.8 | 5.5 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.8 | 2.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 2.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.8 | 5.4 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.8 | 2.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.8 | 2.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.8 | 5.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 9.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.8 | 3.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.7 | 2.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.7 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.7 | 3.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.7 | 2.2 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.7 | 2.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 2.2 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.7 | 1.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.7 | 1.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 2.2 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.7 | 2.9 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.7 | 6.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.7 | 4.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 1.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.7 | 5.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.7 | 2.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.7 | 2.8 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.7 | 1.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.7 | 2.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.7 | 4.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 2.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 4.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.7 | 2.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.7 | 2.8 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.7 | 2.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 2.1 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.7 | 4.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.7 | 2.0 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.7 | 2.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.7 | 2.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 5.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.7 | 4.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
0.7 | 14.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.7 | 2.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.7 | 2.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.7 | 0.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.7 | 3.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.6 | 3.9 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.6 | 3.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.6 | 3.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 1.9 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.6 | 1.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.6 | 7.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.6 | 3.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.6 | 2.6 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 5.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 4.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 8.9 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.6 | 5.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.6 | 3.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.6 | 1.9 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.6 | 1.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.6 | 3.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 8.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.6 | 2.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.6 | 3.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.6 | 19.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.6 | 3.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.6 | 14.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.6 | 3.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.6 | 7.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 2.4 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.6 | 6.5 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.6 | 2.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 1.2 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.6 | 2.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 7.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.6 | 3.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.6 | 9.8 | GO:0010225 | response to UV-C(GO:0010225) |
0.6 | 5.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 3.5 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.6 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.6 | 2.9 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.6 | 8.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.6 | 4.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 1.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 2.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.6 | 7.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.6 | 1.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.6 | 9.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.6 | 1.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 2.8 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.6 | 1.7 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.6 | 1.7 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.6 | 5.6 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.6 | 2.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.6 | 2.8 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.6 | 6.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.6 | 3.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 1.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.5 | 4.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 1.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 0.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.5 | 0.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.5 | 4.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 3.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.5 | 2.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 7.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.5 | 2.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 1.1 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.5 | 2.7 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 1.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 2.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 1.6 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.5 | 2.1 | GO:0035938 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.5 | 1.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 2.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 2.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 5.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 4.7 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.5 | 3.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.5 | 7.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 0.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.5 | 3.1 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 19.9 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.5 | 4.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.5 | 5.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 1.5 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.5 | 0.5 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.5 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.5 | 1.0 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.5 | 2.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 3.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 1.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.5 | 1.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.5 | 4.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.5 | 1.0 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 2.9 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.5 | 0.5 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 14.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.5 | 1.9 | GO:0003360 | brainstem development(GO:0003360) |
0.5 | 1.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 1.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.5 | 6.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 2.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 4.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 1.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 2.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 3.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 1.4 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.5 | 0.5 | GO:1902022 | L-lysine transport(GO:1902022) |
0.5 | 3.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.5 | 1.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.5 | 0.9 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 3.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 3.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 10.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.5 | 12.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 5.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.5 | 2.3 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.5 | 0.5 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.5 | 3.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.5 | 0.9 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.5 | 1.4 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.5 | 1.8 | GO:0097393 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.5 | 4.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 3.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 2.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 1.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 | 1.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 1.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 2.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 2.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 1.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 0.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.4 | 1.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.4 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.4 | 3.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 2.6 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 12.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.4 | 28.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 0.9 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 1.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 2.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.4 | 2.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 3.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 2.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.4 | 1.3 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.4 | 0.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 2.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 2.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 0.9 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.7 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 2.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.4 | 2.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.4 | 1.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 4.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 1.3 | GO:1902161 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
0.4 | 0.4 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.4 | 2.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 0.4 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 2.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 3.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 0.4 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.4 | 0.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.4 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.2 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.4 | 16.4 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.4 | 2.0 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.4 | 1.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.2 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.4 | 1.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.4 | 4.4 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.4 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.4 | 1.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.4 | 1.6 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.4 | 2.4 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.4 | 1.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.4 | 11.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.4 | 3.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 1.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 2.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 4.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.4 | 1.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 0.4 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.4 | 1.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.4 | 2.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.2 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.4 | 1.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 2.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 1.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 1.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 3.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 0.8 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.4 | 2.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 6.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.4 | 2.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 1.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 4.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 1.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 1.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.4 | 1.5 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.4 | 1.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.4 | 1.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.4 | 1.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.4 | 2.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.1 | GO:0046959 | habituation(GO:0046959) |
0.4 | 1.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 4.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.4 | 4.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.4 | 0.4 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.4 | 1.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 1.4 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 0.4 | GO:0003166 | His-Purkinje system development(GO:0003164) bundle of His development(GO:0003166) |
0.4 | 1.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.4 | 2.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.1 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.4 | 6.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.4 | 1.1 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.4 | 1.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 1.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.4 | 5.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 1.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 14.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 2.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 1.0 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.3 | 2.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 1.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 1.4 | GO:0003157 | endocardium development(GO:0003157) |
0.3 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 1.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 0.7 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.3 | 1.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.3 | 3.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 1.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 2.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 1.4 | GO:0002188 | translation reinitiation(GO:0002188) |
0.3 | 0.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 0.3 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.3 | 3.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 3.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.0 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.3 | 0.7 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.3 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 1.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.3 | 0.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.3 | 2.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 2.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.7 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.3 | 2.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 1.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 0.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.3 | 2.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.3 | 0.3 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.3 | 2.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 2.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 1.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 1.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 1.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 1.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 0.3 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 1.3 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.3 | 1.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 5.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.3 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 2.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.3 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 2.8 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 0.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 1.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 1.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 1.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 11.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 4.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 9.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 0.6 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.3 | 6.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 5.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 2.1 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.3 | 3.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 2.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 2.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 2.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 1.5 | GO:0061744 | motor behavior(GO:0061744) |
0.3 | 4.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 2.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 0.3 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.3 | 4.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 1.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 0.9 | GO:0009644 | response to high light intensity(GO:0009644) |
0.3 | 1.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 2.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 2.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 0.9 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.3 | 0.9 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.3 | 2.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 2.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 2.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 4.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.3 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 0.8 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.3 | 4.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.3 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.3 | 0.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 2.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 1.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 3.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 0.6 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 0.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 2.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 3.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 2.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 0.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 6.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.3 | 0.8 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 1.4 | GO:0035546 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.3 | 0.3 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.3 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 0.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 0.5 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.3 | 2.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 1.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 1.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 0.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 8.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 1.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 3.7 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.8 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.3 | 0.8 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.3 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 1.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 8.6 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 1.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 7.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 2.8 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 0.3 | GO:0072179 | nephric duct formation(GO:0072179) |
0.3 | 1.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 0.8 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 1.3 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 1.8 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.3 | 5.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.3 | 0.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.3 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 0.8 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.7 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.2 | 1.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 3.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 2.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 4.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 3.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.5 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.7 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 1.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 2.4 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 1.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 4.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 1.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 2.6 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.2 | 1.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.2 | 2.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 3.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.5 | GO:0032242 | regulation of nucleoside transport(GO:0032242) negative regulation of long term synaptic depression(GO:1900453) |
0.2 | 1.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.5 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 11.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.2 | 2.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 1.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.4 | GO:1990401 | embryonic lung development(GO:1990401) |
0.2 | 2.0 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.4 | GO:2000485 | regulation of glutamine transport(GO:2000485) |
0.2 | 0.4 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 1.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 0.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 3.1 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 1.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 2.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.9 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 0.6 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.2 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.8 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 1.0 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 3.1 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.6 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.2 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.2 | 3.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 1.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.4 | GO:0046726 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 6.7 | GO:0007584 | response to nutrient(GO:0007584) |
0.2 | 3.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 2.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 1.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.6 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.2 | 2.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.2 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 2.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 1.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 3.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.6 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.2 | 1.9 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.2 | 1.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 2.1 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 2.1 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.2 | 1.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 0.6 | GO:0070142 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
0.2 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 3.3 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 2.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 1.3 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.2 | 2.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 1.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 2.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 1.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 6.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.7 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.2 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 1.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 0.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 2.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 2.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.2 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.5 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.2 | 5.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 3.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 4.8 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 0.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.2 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.2 | 0.7 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.2 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 2.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 0.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 1.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 1.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 3.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.5 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.2 | 0.5 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.2 | 1.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.2 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.1 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.8 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.2 | 17.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.5 | GO:0033007 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.2 | 2.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.3 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 1.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 | 0.8 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.2 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 3.3 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 1.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 1.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.4 | GO:0007315 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.1 | 1.0 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 2.4 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 0.3 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.1 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 1.2 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 2.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.3 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.4 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 1.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 1.7 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.6 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.1 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 0.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 1.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.1 | 3.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.5 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.8 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 1.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.7 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.5 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.3 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 2.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:1903540 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.1 | 3.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 2.1 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.7 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.6 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 0.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 1.6 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 2.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 1.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 2.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 1.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.9 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.5 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 1.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 2.7 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 2.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 1.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 1.5 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 2.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 2.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.2 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.7 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.7 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.9 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 6.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.5 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.1 | 1.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.2 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 0.3 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
0.1 | 1.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 0.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 2.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 1.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 12.6 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 1.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 2.3 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.1 | 0.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.2 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 1.0 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.1 | GO:2000451 | positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
0.1 | 4.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 4.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 1.6 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.4 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 1.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 2.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.4 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 1.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 1.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 3.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 1.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.2 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.5 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.2 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.2 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.1 | 0.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 1.3 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:0035883 | enteroendocrine cell differentiation(GO:0035883) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 1.7 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.2 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.1 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 2.8 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 1.9 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.1 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.2 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.2 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.1 | 0.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 1.7 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 0.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 2.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.1 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 1.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 3.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.4 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 1.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.9 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.1 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.4 | GO:0021767 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.1 | 0.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.8 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.1 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 4.8 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.1 | 0.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.1 | 0.2 | GO:0051194 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.4 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 4.0 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 0.3 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.7 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 1.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 1.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 2.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 1.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.8 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.2 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.0 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.3 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 1.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.3 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 1.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.3 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.2 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 1.7 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 1.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0045716 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.1 | GO:0045117 | azole transport(GO:0045117) |
0.0 | 3.0 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:1901317 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.0 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:1990743 | protein sialylation(GO:1990743) |
0.0 | 0.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.1 | GO:0044126 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.3 | 14.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
2.1 | 6.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
2.0 | 5.9 | GO:0044317 | rod spherule(GO:0044317) |
1.8 | 1.8 | GO:0090537 | CERF complex(GO:0090537) |
1.6 | 7.9 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.4 | 9.6 | GO:0070695 | FHF complex(GO:0070695) |
1.4 | 9.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.3 | 9.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.3 | 3.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.3 | 3.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.3 | 3.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
1.2 | 3.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.2 | 15.3 | GO:0031209 | SCAR complex(GO:0031209) |
1.1 | 3.4 | GO:0018444 | translation release factor complex(GO:0018444) |
1.1 | 14.6 | GO:0043219 | lateral loop(GO:0043219) |
1.1 | 5.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.1 | 2.2 | GO:0001739 | sex chromatin(GO:0001739) |
1.1 | 15.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.0 | 1.0 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
1.0 | 8.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.0 | 5.0 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.0 | 3.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.0 | 21.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.0 | 11.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 3.8 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
1.0 | 5.8 | GO:0005955 | calcineurin complex(GO:0005955) |
1.0 | 22.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.0 | 2.9 | GO:0031417 | NatC complex(GO:0031417) |
0.9 | 6.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.9 | 4.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.9 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.9 | 6.4 | GO:0097413 | Lewy body(GO:0097413) |
0.9 | 2.7 | GO:0034657 | GID complex(GO:0034657) |
0.9 | 3.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 2.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.8 | 10.8 | GO:0016589 | NURF complex(GO:0016589) |
0.8 | 4.6 | GO:0000938 | GARP complex(GO:0000938) |
0.7 | 2.9 | GO:0036019 | endolysosome(GO:0036019) |
0.7 | 3.5 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 1.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 2.8 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.7 | 2.8 | GO:0044307 | dendritic branch(GO:0044307) |
0.7 | 2.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.7 | 3.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.6 | 8.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 9.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.6 | 5.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 2.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 7.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 1.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 2.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 5.7 | GO:0016342 | catenin complex(GO:0016342) |
0.6 | 12.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 11.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 4.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 6.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.5 | 2.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 1.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 2.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 2.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 2.0 | GO:0060187 | cell pole(GO:0060187) |
0.5 | 14.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 1.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.5 | 4.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 2.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 2.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 1.8 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.4 | 5.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.4 | 9.2 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.4 | 3.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 3.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.7 | GO:0097447 | dendritic tree(GO:0097447) |
0.4 | 1.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.4 | 1.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 3.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 0.9 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 1.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.4 | 1.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 2.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 2.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.4 | 4.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 2.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 1.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 2.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 4.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 2.0 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 3.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 12.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 2.7 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 2.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.4 | 1.1 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.4 | 3.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 3.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 16.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.4 | 1.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 1.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 0.4 | GO:1903349 | omegasome membrane(GO:1903349) |
0.4 | 6.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 1.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.4 | 1.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.3 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 4.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 6.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 7.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 7.9 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 3.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 4.0 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 8.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 0.9 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.3 | 0.9 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.3 | 2.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 0.9 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 2.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 1.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 0.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 2.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 0.9 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.3 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.3 | 2.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 5.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.3 | 0.6 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 3.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 2.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 0.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 15.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 2.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 2.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 19.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 3.8 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 2.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.8 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 3.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 11.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 4.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.5 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 1.2 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 16.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 4.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 3.6 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 59.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.2 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 7.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 4.2 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 3.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
0.2 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 2.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 2.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 4.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 2.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 1.9 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 3.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 3.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 2.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.8 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 4.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 2.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 3.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 3.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 3.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 34.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 2.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 4.1 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 5.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 3.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 4.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 11.0 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 2.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 2.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 4.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 0.2 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 2.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 12.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 2.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 8.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 3.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 3.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 6.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 4.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 2.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 3.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 2.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 33.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.8 | GO:0070187 | telosome(GO:0070187) |
0.1 | 10.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.8 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 2.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.9 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 5.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 2.4 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 3.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 3.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 7.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 1.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 18.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 7.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:0043512 | inhibin A complex(GO:0043512) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 3.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.7 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 3.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 2.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.3 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.3 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 2.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 2.9 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 16.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 36.7 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 23.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 7.5 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 7.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 2.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 10.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 8.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 3.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 1.6 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 7.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 1.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.2 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 2.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 14.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 87.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.9 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.9 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.2 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 35.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 21.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 1.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.2 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
2.9 | 14.7 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
2.8 | 8.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
2.8 | 13.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
2.7 | 8.0 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
2.1 | 6.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
2.0 | 6.1 | GO:0008431 | vitamin E binding(GO:0008431) |
2.0 | 7.8 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.9 | 5.7 | GO:0031208 | POZ domain binding(GO:0031208) |
1.9 | 5.6 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
1.8 | 5.3 | GO:0019002 | GMP binding(GO:0019002) |
1.8 | 5.3 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
1.7 | 5.2 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.6 | 8.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.6 | 4.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.6 | 9.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.5 | 7.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.4 | 12.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.3 | 8.1 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.3 | 4.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
1.3 | 7.9 | GO:0002135 | CTP binding(GO:0002135) |
1.3 | 3.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.2 | 18.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.2 | 4.9 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.2 | 12.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.2 | 7.1 | GO:0097016 | L27 domain binding(GO:0097016) |
1.2 | 4.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.2 | 8.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.1 | 4.6 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
1.1 | 3.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.1 | 5.6 | GO:2001070 | starch binding(GO:2001070) |
1.1 | 3.3 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.1 | 3.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 6.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 3.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.1 | 3.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.1 | 3.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
1.1 | 2.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.0 | 4.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
1.0 | 3.0 | GO:0008940 | nitrate reductase activity(GO:0008940) |
1.0 | 11.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.0 | 11.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.0 | 3.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 1.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 19.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.0 | 5.9 | GO:0004103 | choline kinase activity(GO:0004103) |
1.0 | 6.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.9 | 17.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.9 | 5.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.9 | 2.8 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.9 | 2.7 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.9 | 5.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.9 | 2.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.9 | 4.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 6.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 3.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.9 | 2.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.9 | 4.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.9 | 8.6 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.8 | 6.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.8 | 3.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 4.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 2.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.8 | 9.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.8 | 5.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.8 | 8.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.8 | 4.8 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.8 | 2.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 3.1 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.8 | 2.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.8 | 4.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.8 | 4.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.7 | 3.0 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.7 | 3.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 9.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.7 | 5.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.7 | 4.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 4.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 2.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.7 | 4.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 2.0 | GO:0005118 | sevenless binding(GO:0005118) |
0.7 | 2.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 3.9 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.6 | 12.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.6 | 2.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 3.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.6 | 3.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.6 | 5.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.6 | 6.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.6 | 4.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 6.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 4.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 3.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 15.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 7.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 2.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.6 | 10.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 4.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 1.8 | GO:0008158 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.6 | 2.9 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.6 | 4.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.6 | 2.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.6 | 2.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.6 | 2.3 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.6 | 9.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 2.8 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 1.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.6 | 5.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.6 | 8.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.6 | 3.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.6 | 3.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 4.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 2.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 0.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 4.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 14.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 5.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 13.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 4.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.5 | 2.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 2.0 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.5 | 4.6 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 2.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 11.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 8.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 1.0 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.5 | 4.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.5 | 2.4 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.5 | 1.9 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.5 | 2.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.5 | 5.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 1.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.5 | 1.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 1.4 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.5 | 2.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.5 | 0.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 1.4 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) |
0.5 | 1.9 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.5 | 2.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 2.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 1.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 1.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.5 | 4.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 2.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.8 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.4 | 1.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.3 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.4 | 0.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 2.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 4.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 6.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 4.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 4.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 1.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.4 | 4.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.4 | 4.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 3.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 3.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 5.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.4 | 1.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.2 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.4 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 2.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 2.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 7.2 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 2.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.4 | 1.2 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.4 | 2.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 2.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.4 | 4.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 2.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 5.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 5.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 6.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 2.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 10.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 7.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 1.1 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.4 | 1.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.5 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.4 | 1.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 9.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 0.8 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.4 | 2.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.4 | 1.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.4 | 5.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 9.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 2.6 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 6.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 1.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.4 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.1 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.4 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.4 | 1.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.4 | 12.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 10.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 2.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 1.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.4 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.3 | 1.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 16.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 3.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 12.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 3.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 7.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 3.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.3 | 5.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 7.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 4.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 2.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 1.0 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.3 | 1.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 1.0 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.3 | 8.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 2.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 2.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 5.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 20.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 6.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 0.9 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.3 | 2.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.3 | 3.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.9 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.3 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 2.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 2.9 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.3 | 9.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 1.5 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.3 | 3.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 4.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 4.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 5.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 0.8 | GO:0046911 | metal chelating activity(GO:0046911) |
0.3 | 73.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 1.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 5.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 5.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.3 | 0.5 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.3 | 1.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.3 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 2.6 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 2.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 1.0 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 4.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 4.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 22.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.7 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.2 | 2.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 3.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.2 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.2 | 3.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 8.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 5.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 2.2 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.7 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.2 | 2.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 2.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 2.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 2.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.2 | 1.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 1.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 8.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 1.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 4.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 2.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 8.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 5.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 3.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 5.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 3.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 1.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 10.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 4.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 4.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 3.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 2.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 0.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 1.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 4.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 5.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 0.4 | GO:0070404 | NADH binding(GO:0070404) |
0.2 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 1.8 | GO:0004532 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.2 | 7.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.6 | GO:0030977 | taurine binding(GO:0030977) |
0.2 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 14.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 2.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 2.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.2 | 2.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 1.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 2.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.8 | GO:0016433 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (adenine) methyltransferase activity(GO:0016433) |
0.2 | 1.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 2.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.2 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 2.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 3.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 3.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 10.3 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 7.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 1.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.3 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.2 | 25.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.7 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.2 | 1.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 2.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 1.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 0.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 10.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.2 | 9.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 3.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.6 | GO:0090554 | phosphatidylcholine transporter activity(GO:0008525) phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 4.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 2.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 3.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 3.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.9 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 1.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 5.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 2.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 2.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 8.3 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 1.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 8.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 4.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 2.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.4 | GO:0050510 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 3.4 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.1 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 3.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 13.2 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.3 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 6.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.1 | 1.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 13.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 2.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.1 | 0.9 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.6 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 5.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 2.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 2.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 2.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 3.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 3.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 1.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 3.6 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 1.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.1 | 1.2 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 7.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 3.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 2.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 3.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 4.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.2 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 8.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.5 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 0.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 2.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.3 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.1 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.5 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 6.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 1.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 2.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 1.0 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 3.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.9 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 3.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 2.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 24.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 1.9 | GO:0004620 | phospholipase activity(GO:0004620) |
0.0 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 1.9 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 3.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.9 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.0 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.7 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 2.2 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.5 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 3.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 6.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.2 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 74.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 34.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.7 | 4.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 34.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 30.3 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 18.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 9.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 10.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 16.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 2.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 12.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 27.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 19.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 16.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 10.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 22.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 5.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 16.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 3.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 5.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 11.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 2.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 5.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 11.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 6.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 7.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 14.7 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 3.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 13.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 2.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 8.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 10.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 8.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 5.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 4.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 2.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 2.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 5.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 3.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 3.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 5.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 4.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 3.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 1.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 2.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.4 | 1.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.3 | 5.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.2 | 23.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 15.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.2 | 36.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.0 | 4.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.9 | 15.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.9 | 11.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.8 | 10.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 21.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.7 | 15.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.7 | 9.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.7 | 21.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.7 | 2.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.7 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 11.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 19.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 11.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.6 | 12.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.6 | 11.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.6 | 2.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 2.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 12.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 9.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 9.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 7.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 5.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 6.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 10.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 7.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 3.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.5 | 6.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.5 | 7.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 14.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 6.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 7.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 4.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 8.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 8.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 7.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.4 | 5.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 4.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 5.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 8.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 7.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 7.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 25.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 5.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 8.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 6.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 8.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 4.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 5.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 10.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 7.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 7.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 6.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 5.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 15.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 6.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 3.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 7.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 1.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 2.6 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 8.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 2.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 7.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 2.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 9.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 2.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 3.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 2.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 3.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 3.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 3.9 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 1.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 8.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 3.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 3.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 2.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 1.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 5.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 5.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 3.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 5.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 5.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 6.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 8.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 3.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 14.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 5.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 1.5 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |